437 filings
Page 3 of 22
8-K
xcsmi6cgfg6r17
15 Jun 23
Other Events
4:06pm
8-K
bh4zxxe10hqj
10 May 23
AcelRx Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Corporate Update
4:11pm
8-K
xy60v3hpmeu8mx d55
28 Apr 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:06pm
UPLOAD
bnkm8ov x2z
11 Apr 23
Letter from SEC
12:00am
CORRESP
63peenun3ji
11 Apr 23
Correspondence with SEC
12:00am
8-K
e5jozjqzm3t0cmr552
7 Apr 23
AcelRx Pharmaceuticals Announces Closing of Divestment of DSUVIA® to Alora Pharmaceuticals
3:37pm
8-K
egrskcu
30 Mar 23
AcelRx Pharmaceuticals Reports Full Year and Fourth Quarter 2022 Financial Results and Provides Corporate Update
4:10pm
UPLOAD
lmbs2lgi xfb3c6k51
30 Mar 23
Letter from SEC
12:00am
8-K
qgiu6q
16 Mar 23
Entry into a Material Definitive Agreement
4:15pm
8-K
potxpgfy
29 Dec 22
Other Events
6:03am
424B5
nmafp 6ddyuf
28 Dec 22
Prospectus supplement for primary offering
5:26pm
8-K
th1u76 2hnyu
5 Dec 22
Termination of a Material Definitive Agreement
5:25pm
EFFECT
u037bgn0963oi
23 Nov 22
Notice of effectiveness
12:15am
424B7
tctgt2xu
22 Nov 22
Prospectus with selling stockholder info
4:29pm
CORRESP
fqt9ewpk2 u3w1jg25q
21 Nov 22
Correspondence with SEC
12:00am
UPLOAD
jph8g39yt737
21 Nov 22
Letter from SEC
12:00am